Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Zacks Research Lowers Earnings Estimates for Gilead Sciences

Summary
Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Zacks Research decreased their Q1 2028 earnings per share estimates for Gilead Sciences in a report released on Thursday, October 1st. Zacks Research analyst Team now expects that the biopharmaceutical company will post earnings of $2.14 per share

1 Articles

MarketBeatMarketBeat
Center

Palomar Stock Earnings Estimates Lowered by Zacks Research

Palomar Holdings, Inc. (NASDAQ:PLMR - Free Report) - Research analysts at Zacks Research lowered their FY2026 EPS estimates for Palomar in a report released on Thursday, October 1st. Zacks Research analyst Team now expects that the company will earn $9.17 per share for the year, down from their prio

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Monday, October 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Gilead Sciences icon

Gilead Sciences

California, United States icon

California, United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal